Spotting cancer at an early stage is important!
Recognize it in time
Many cancers develop for years without symptoms. Screening looks for early molecular signals in people who feel healthy, so that they and their physician can act sooner.
AveGene screening analyses genetic variants in DNA from a blood or urine sample using next-generation sequencing (NGS). It is an early-warning tool, not a diagnosis. A diagnosis can only be made by a physician, based on your full medical picture.
Only authorized medical personnel are permitted to make diagnoses!
Efficient procedure for rapid screening of multiple critical diseases and genetic predispositions via blood samples utilizing Next Generation Sequencing technology. The World's most advanced technology for assessing health status at the molecular level is now accessible to you in the most discreet manner possible.
Create your account. Go to the Client Zone on avegene.com and complete the screening form: your details, a short health questionnaire, a check that you understand what screening can and cannot tell you, and your consents. You sign it electronically and your account is created. A contracted physician can also create the account for you.
Choose who confirms the indication. In the same form you choose either your own physician or a contracted physician from our list. In several countries a physician’s indication is required by law. More importantly, your physician helps you understand whether this screening is right for you.
Get your kit. Your physician can hand you a kit directly. If you order online, we send it by post once your physician has confirmed the indication. Kits are also available at selected pharmacies and from our local distributors. Enter its serial number and activation code in the Client Zone.
Give your sample. Your blood can be drawn anywhere by a healthcare professional authorised to take venous blood, for example your own physician, a nurse, a hospital or a clinic. You do not need to visit an AveGene physician. Urine for HPV screening you collect at home. Write the date and time on the tubes.
Send it to us. Pack the sample in the transport box from your kit and send it by courier to a collection centre or to our laboratory. Standard post is not allowed for biological samples in most countries. Blood in our tubes stays stable for up to 14 days at room temperature. On arrival, we always measure DNA quality to make sure the sample was not damaged in transport.
Laboratory analysis. The laboratory process can start as soon as your sample arrives and we have checked your completed informed consent and your physician’s indication, both recorded in the Client Zone of the AveGene Health Care portal.
Note: The laboratory never starts without a valid physician’s indication and your signed consent. If your form or indication is still missing after you have paid, we send you a short e-mail reminder.
Your screening report. A geneticist reviews the data and our oncologists interpret the findings. Your encrypted report appears in the Client Zone and we let you know by e-mail. The raw sequencing data (about 4–5 GB) stay in the Client Zone for 30 days, then they are deleted automatically.
Sequencing is a technique used to ascertain the arrangement of nucleotides in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), as well as to establish the sequence of amino acids in proteins. In other words, it is a technique for identifying the matrix of ADGT nucleotides. To explain the method more; we isolate DNA/RNA samples from blood or plasma, decompose the matrix into billions of individual nucleotides, and then employ thorough bioanalytic techniques to analyse fragments that are specific or semi-specific to certain diseases. If specific fragments are identified, we also assess their frequency and assign a relative risk factor to each fragment. Certain fragments may also be evaluated in relation to other ones. Oncology diseases are often characterized by a wide variety of specific or semi-specific fragments. We use two primary approaches: the European CEGAT and the American ACME. Each association rates the pathogenic variants somewhat differently, but we strive to accommodate both perspectives. Read more at the HOW TO UNDERSTAND THE RESULTS page.
Learn more about the reports and how it should be understood. Please keep in mind the results shall always be consulted with your Medical Doctor who knows your physical status. This screening program shall act as an early detection alert. We do not provide diagnostics!
Oncogenic viruses like HPV, Hepatitis, or HIV, along with oncogenic agents such as heavy metals and radiation, play a crucial role in promoting genetic mutations, which is commonly called a cancer.
Human papilloma virus (HPV)
Human papilloma virus (HPV) comprises over 100 viruses that are typically transmitted through sexual contact. HPV is quite prevalent and has the potential to infect the skin, genital area, and throat, leading to specific cancers and genital warts in both men and women. Many infections are asymptomatic, leaving numerous individuals unaware of their infection status. The majority of new infections are found among young individuals in their teenage years and early twenties. While many infections resolve independently, the process may take as long as two years for complete resolution. Certain HPV infections that persist may advance to cancer. HPV is responsible for nearly all cases of cervical cancer in the US, as well as a significant number of cancers affecting the vulva, vagina, penis, anus, and the back of the throat. The most prevalent HPV-related cancer is oropharyngeal cancer, primarily affecting men. Individuals can transmit the virus without displaying any symptoms, and this can occur even if they were infected years prior.